Indeed, the upregulated ALKBH5 post-transcriptionally weakens LYPD1 expression in an m6A-IGF2BP-dependent manner, inhibiting HCC cell proliferation and invasion (96). This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.